Patents by Inventor Erwin Satrya Budiman

Erwin Satrya Budiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12171556
    Abstract: Methods, systems and devices for providing improved calibration accuracy of continuous and/or in vivo analyte monitoring systems based at least in part on insulin delivery information are provided. Many of the embodiments disclosed herein can determine appropriate conditions for performing a calibration of the analyte sensor in view of the scheduled delivery of insulin or administered insulin amount. One or more other parameters or conditions can also be incorporated to improve calibration accuracy including, for example, the physiological model associated with a patient, meal information, exercise information, activity information, disease information, historical physiological condition information, as well as other types of information. Furthermore, according to some embodiments, calibration of the analyte sensor can be delayed or not performed at all, if appropriate conditions are not met.
    Type: Grant
    Filed: January 21, 2022
    Date of Patent: December 24, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Erwin Satrya Budiman
  • Patent number: 12171548
    Abstract: Systems, methods and apparatus are provided for determining an estimate of an analyte level over time. The invention includes sampling sensor data using an analyte sensor positioned at least partially subcutaneously; storing a plurality of datasets of sensor data, each at a different rate; determining an estimated analyte level based on the datasets; and outputting the estimated analyte level to a display. Numerous additional aspects are disclosed.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: December 24, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Erwin Satrya Budiman
  • Publication number: 20240377383
    Abstract: The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous glucose sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.
    Type: Application
    Filed: July 25, 2024
    Publication date: November 14, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20240293085
    Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.
    Type: Application
    Filed: May 7, 2024
    Publication date: September 5, 2024
    Applicant: Abbott Diabetes care Inc.
    Inventors: Gary Alan Hayter, Nathan Christopher Crouther, Michael Love, Erwin Satrya Budiman, Daniel Milfred Bernstein
  • Publication number: 20240277271
    Abstract: Methods, devices, systems, and computer program products are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of an associated analyte monitoring system. In certain embodiments, methods are provided that improve the user experience of using an analyte monitoring system. Certain embodiments of the present disclosure include features that reduce the amount of calibration or re-calibration performed by the analyte monitoring system. More specifically methods of using a suspect calibration attempt to avoid having to recalibrate by adjusting the calibration or mitigating effects of sensor signal attenuation that caused the calibration attempt to be suspect are provided. Additional features are disclosed.
    Type: Application
    Filed: May 2, 2024
    Publication date: August 22, 2024
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Publication number: 20240252076
    Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.
    Type: Application
    Filed: April 16, 2024
    Publication date: August 1, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christain Dunn
  • Publication number: 20240225559
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Application
    Filed: March 20, 2024
    Publication date: July 11, 2024
    Inventors: Erwin Satrya BUDIMAN, Kenneth J. DONIGER, Timothy C. DUNN, Nathan C. CROUTHER, Glenn BERMAN, Howard A. WOLPERT
  • Publication number: 20240180450
    Abstract: Methods, devices, and systems are provided for correcting lag in measurements of glucose concentration level in interstitial fluid. A method includes defining a scaling factor for lag correction, receiving glucose data from the glucose sensor, the sensor data including historical glucose sensor data over a plurality of intervals, defining a probability density function of the glucose data over at least a portion of one of the plurality of intervals, determining a value of the scaling factor based on the probability density function and a normalized analyte variability ratio, and computing lag corrected values based on the determined value of the scaling factor. Numerous additional features are disclosed.
    Type: Application
    Filed: February 12, 2024
    Publication date: June 6, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Erwin Satrya Budiman
  • Publication number: 20240164721
    Abstract: Systems, methods and apparatus are provided for estimating meal start and peak meal response times are provided based on time series of sampled glucose data collected. Numerous additional aspects are disclosed.
    Type: Application
    Filed: June 20, 2023
    Publication date: May 23, 2024
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Patent number: 11896371
    Abstract: Methods, devices, and systems are provided for correcting lag in measurements of analyte concentration level in interstitial fluid. The invention includes receiving a signal representative of sensor data from an analyte monitoring system related to an analyte level measured over time, computing rates of change of the sensor data for a time period of the sensor data, computing a rate distribution of the rates of change, transforming the rate distribution into a linear arrangement, determining a best-fit line for the transformed rate distribution, computing a slope of the best-fit line; and using the slope of the best-fit line as a representation of a variability of the analyte level to adjust an amount of lag correction applied to the sensor data. Numerous additional features are disclosed.
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: February 13, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Erwin Satrya Budiman
  • Patent number: 11864894
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: January 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Publication number: 20230404449
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, receiving the data corresponding to an analyte level, providing a notification on the user interface that comprises a request for a blood analyte measurement, receiving an indication, based on the blood analyte measurement, of an absence of the error condition, and in response to receiving the indication, configuring the user interface to report the data corresponding to the analyte level, where the user interface was previously configured to not report the data corresponding to the analyte level.
    Type: Application
    Filed: August 30, 2023
    Publication date: December 21, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Patent number: 11779248
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: October 10, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20230255518
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include processing sampled data from analyte sensor, determining a non-attenuated sensitivity value associated with the analyte sensor, determining a representative sensitivity of the sensor for each group of multiple groups of data points from the analyte sensor, wherein the representative sensitivity is based on the corresponding sensitivities of pairs of data points in the group, selecting one or more of the representative sensitivities based on the selected representative sensitivities satisfying one or more criteria, determining a non-attenuated sensitivity based on a weighted average of the selected representative sensitivities, and applying the determined non-attenuated sensitivity to the data points obtained from the analyte sensor to estimate an analyte level.
    Type: Application
    Filed: October 10, 2022
    Publication date: August 17, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Erwin Satrya Budiman
  • Patent number: 11717225
    Abstract: Systems, methods and apparatus are provided for estimating meal start and peak meal response times are provided based on time series of sampled glucose data collected. Numerous additional aspects are disclosed.
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: August 8, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Publication number: 20230200687
    Abstract: Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.
    Type: Application
    Filed: March 6, 2023
    Publication date: June 29, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Daniel Milfred Bernstein, Erwin Satrya Budiman
  • Publication number: 20230190156
    Abstract: Methods, devices, systems, and computer program products are provided to improve sensitivity calibration of an in vivo analyte sensor and usability of an associated analyte monitoring system. In certain embodiments, methods are provided that improve the user experience of using an analyte monitoring system. Certain embodiments of the present disclosure include features that reduce the amount of calibration or re-calibration performed by the analyte monitoring system. More specifically methods of using a suspect calibration attempt to avoid having to recalibrate by adjusting the calibration or mitigating effects of sensor signal attenuation that caused the calibration attempt to be suspect are provided. Additional features are disclosed.
    Type: Application
    Filed: February 24, 2023
    Publication date: June 22, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin Satrya Budiman, Gary Alan Hayter
  • Publication number: 20230157643
    Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.
    Type: Application
    Filed: January 6, 2023
    Publication date: May 25, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Nathan Christopher Crouther, Michael Love, Erwin Satrya Budiman, Daniel Milfred Bernstein
  • Patent number: 11596330
    Abstract: Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: March 7, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Daniel Milfred Bernstein, Erwin Satrya Budiman
  • Publication number: 20230051983
    Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.
    Type: Application
    Filed: October 31, 2022
    Publication date: February 16, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn